326 related articles for article (PubMed ID: 29035823)
21. Co-delivery nanocarriers targeting folate receptor and encapsulating 2-deoxyglucose and α-tocopheryl succinate enhance anti-tumor effect in vivo.
Lei X; Li K; Liu Y; Wang ZY; Ruan BJ; Wang L; Xiang A; Wu D; Lu Z
Int J Nanomedicine; 2017; 12():5701-5715. PubMed ID: 28848348
[TBL] [Abstract][Full Text] [Related]
22. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
Yu D; Li W; Zhang Y; Zhang B
Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
[TBL] [Abstract][Full Text] [Related]
23. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.
Moutinho CG; Matos CM; Teixeira JA; Balcão VM
J Drug Target; 2012 Feb; 20(2):114-41. PubMed ID: 22023555
[TBL] [Abstract][Full Text] [Related]
24. Bisphosphonate-decorated lipid nanoparticles designed as drug carriers for bone diseases.
Wang G; Mostafa NZ; Incani V; Kucharski C; Uludağ H
J Biomed Mater Res A; 2012 Mar; 100(3):684-93. PubMed ID: 22213565
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
[TBL] [Abstract][Full Text] [Related]
26. Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy.
Jeong K; Kang CS; Kim Y; Lee YD; Kwon IC; Kim S
Cancer Lett; 2016 Apr; 374(1):31-43. PubMed ID: 26854717
[TBL] [Abstract][Full Text] [Related]
27. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.
Wang Y; Zhang H; Hao J; Li B; Li M; Xiuwen W
Drug Deliv; 2016 May; 23(4):1398-403. PubMed ID: 26079530
[TBL] [Abstract][Full Text] [Related]
28. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
Torchilin VP
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
[TBL] [Abstract][Full Text] [Related]
29. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
He Y; Su Z; Xue L; Xu H; Zhang C
J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in nanocarrier-loaded gels: Which drug delivery technologies against which diseases?
Pitorre M; Gondé H; Haury C; Messous M; Poilane J; Boudaud D; Kanber E; Rossemond Ndombina GA; Benoit JP; Bastiat G
J Control Release; 2017 Nov; 266():140-155. PubMed ID: 28951319
[TBL] [Abstract][Full Text] [Related]
31. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
[TBL] [Abstract][Full Text] [Related]
32. Improving combination cancer therapy: the CombiPlex
Tolcher AW; Mayer LD
Future Oncol; 2018 Jun; 14(13):1317-1332. PubMed ID: 29363994
[TBL] [Abstract][Full Text] [Related]
33. Liposomes a vesicular nanocarrier: potential advancements in cancer chemotherapy.
Kumar P; Gulbake A; Jain SK
Crit Rev Ther Drug Carrier Syst; 2012; 29(5):355-419. PubMed ID: 22876808
[TBL] [Abstract][Full Text] [Related]
34. Targeted pharmaceutical nanocarriers for cancer therapy and imaging.
Torchilin VP
AAPS J; 2007 May; 9(2):E128-47. PubMed ID: 17614355
[TBL] [Abstract][Full Text] [Related]
35. Recent Trends in Clinical Trials Related to Carrier-Based Drugs.
Tagami T; Ozeki T
J Pharm Sci; 2017 Sep; 106(9):2219-2226. PubMed ID: 28259767
[TBL] [Abstract][Full Text] [Related]
36. Nanocarriers for the simultaneous co-delivery of therapeutic genes and anticancer drugs.
Choudhury NN; He H
Curr Pharm Biotechnol; 2012 Jun; 13(7):1317-31. PubMed ID: 22201588
[TBL] [Abstract][Full Text] [Related]
37. Advances in nanocarriers as drug delivery systems in Chagas disease.
Quijia Quezada C; Azevedo CS; Charneau S; Santana JM; Chorilli M; Carneiro MB; Bastos IMD
Int J Nanomedicine; 2019; 14():6407-6424. PubMed ID: 31496694
[TBL] [Abstract][Full Text] [Related]
38. Triple Block Nanocarrier Platform for Synergistic Cancer Therapy of Antagonistic Drugs.
Surnar B; Jayakannan M
Biomacromolecules; 2016 Dec; 17(12):4075-4085. PubMed ID: 27936725
[TBL] [Abstract][Full Text] [Related]
39. Drug and gene co-delivery systems for cancer treatment.
Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
[TBL] [Abstract][Full Text] [Related]
40. Liposomal drug delivery systems: from concept to clinical applications.
Allen TM; Cullis PR
Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
